MYO1G and acute lymphoblastic leukemia: Studies under way will evaluate the ability of B cells over expressing myo1g to migrate compared to cells expressing low levels of this protein, with those studies we will try to correlate high expression of Myo1g with clinical outcomes in patients with ALL.